MedTrace Logo

Efficacy and Safety of Ibuprofen in Patients With Ankle Injuries

NCT01563289 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2013-05-08

No results posted yet for this study

Summary

The objective of the study is to evaluate the efficacy and safety of Ibuprofen in patients with ankle injuries.

Conditions

Interventions

DRUG

Ibuprofen

3 times a day

DRUG

Placebo

3 times a day

Sponsors & Collaborators

  • Orion Corporation, Orion Pharma

    lead INDUSTRY

Principal Investigators

  • Juha-Pekka Kaukonen, MD · Terveystalo Lahti

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01563289 on ClinicalTrials.gov